GlobeStar Therapeutics Corp (GSTC)

[BluePineCapital]

Been here for a few years. Ifff (and you always have to go with “IF” in the otc) the latest tweet from Globestar has any substance of it, a timeline can be somewhat formed and kept in the back of one’s mind to not get overly excited, or know what to expect. Trading is not my main source of income so it is easier for me to be patient as I am still youngish. I can understand if trading is the main source of your income, it is not easy to wait and hold and trading the small pumps might be better.

But if a toxicity study can be initiated by end of February, give or take 4 to 6 weeks for results on a study of 12 - 18 rats, will bring us mid April for full toxicology report.

Submission to FDA and back and forth for trial design will take another 45 - 60 days.

Phase 1 trial, blinded study with 20 - 45 MS patients 3 to 6 months to measure a safety profile in humans will bring us to the Oct - Dec timeline.

If Orphan drug status can be obtained, then we would only need to complete a phase 2 study and approval can be granted and drug combo can be sold while a on-going phase 3 is conducted.

I doubt many here are interested in staying well into 2025 for a phase 2, but a solid phase 1 with results could potentially bring us to 100 mil/150 mil market cap.

Let’s say we balloon to a 2 Billion O/S. Solid phase 1 get us to a median 125mil market cap and an approx .06/.065 share price.

Now the OTC isn’t a perfect market so we can either undershoot or overshoot that market cap. I’ve seen ghost shells trade 500 mil market cap with no real business.

No-one really knows what will happen here, but I like my chances with GSTC than I do with the mega millions.